Stem Cell Innovations (SCIA) ICO Review, Rating, Token Price
Stem Cell Innovations is changing the face of healthcare by expanding access to stem cell research, development, and treatments around the world using blockchain technology. At SCI, we are devoted to the international research, development, and implementation of stem cell therapy. We are also expanding our network with professionals, labs, clinics, hospitals, and nonprofit organizations.
Website Whitepaper One Pager
Stem Cell Innovations (SCIA) ICO Information
|Name||Stem Cell Innovations : Stem Cells on Blockchain|
|Token Price||1 SCIA = 0.15 USD|
|Token for Sale||240,000,000 SCIA (30%)|
|Pre-Sale Date||09/17/2019 - 10/29/2018|
|Token Sale Date||11/21/2018 - 01/17/2019|
|Token Sale Closes [ ] from now|
Stem Cell Innovations is steadfast in its international research, development, and implementation of stem cell therapy. We work to expand our network with professionals, labs, clinics, hospitals, and nonprofit organizations around the world to further this research and development. our ultimate goal is to connect people who need treatment with a dedicated team of professionals who can provide personalized solutions based on patient factors and demographics collected in our dual blockchain-supported platform.
A lack of communication and access continues to plague the medical community in many areas of the world. At SCI, we believe such communication, access, and connections should be convenient and available when needed, just as so many other services are in modern society. With so much information at our fingertips, it was only a matter of time before stem cell research and treatment became mainstream and SCI is ready to take research and treatment to the next level. Can you imagine a world where every person, regardless of location, will be able to connect with a doctor instantly? We did, and we are building the Stem Cell Innovations Application (SCIApplication) in which such transactions can occur. What’s more, the same connection will facilitate determinations of how much information to share, who to share it with, and when based on a patient’s preferences.
Our vision is to provide a safe storage solution for users’ medical data and give those users control over their individual stem cell records. Data related to a user’s stem cell needs will be stored on the SCI blockchain. Such data will be accessible via our secure application. With access to our application, users will have the ability to not only share, but also limit the information doctors and medical organizations can see in an individual medical profile. users will also have the ability to provide access to network providers to view individually-owned stem cell records for a limited time to facilitate treatment or consultation.
The SCIApplication and website will be in full compliance with the Health Insurance Portability and Accountability Act of 1996 privacy regulations (HIPAA), and will keep user information safe and secure. In case of an emergency, users will be able to provide medical history to emergency responders in seconds via the SCIApplication on the user’s phone.
Information, such as names and dosages of medications, as well as previous surgeries and other medical information can be crucial in an emergency situation. Such information will be stored in the SCIApplication so that emergency care providers can quickly access, understand, and provide needed medical attention based on a user’s profile and accessible information.
In addition to providing secure access to a user’s medical information, the SCIApplication will allow users to seamlessly register for life insurance policies, bone marrow donor registries, and organ donation registries. furthermore, the SCIApplication will also enable users to access their individualized stem cell profile, which will facilitate access to stem cell therapies and services in a convenient and straightforward manner. our goal is to bring stem cell therapies into the mainstream medical community while providing harmonious access to medical records for patients and their doctors. It is our vision to empower patients and reduce inefficiency in their access to medical care around the world.
|Accepting||BTC, ETH, LTC, FIAT|
|Restricted Countries||United States of America, China, Cuba, Iran, Korea, Syria, Crimea|
|Min. Purchase||Pre-Sale = 500 USD
Main Sale = 0.4 ETH
|Max. Purchase||4,000 ETH|
Day 1-7 = 60%
Day 8-14 = 55%
Day 15-21 = 50%
Day 22-28 = 45%
Day 29-42 = 40%
Main Sale :
Day 43-54 = 30%
Day 55-69 = 25%
Day 70-End = 15%
Establishment of Camden RAD, LLC, a company devoted to stem cell research and development.
Camden RAD, LLC is rebranded as Stem Cell Innovations, and a new company is established, based on blockchain technology.
Advanced research begins to determine market and development opportunities.
Attended Token 2049 conference in Hong Kong.
Attended Stem Cell Summit at the University of California in Los Angeles (UCLA).
Attended CBC conference in San Francisco, CA.
Attended ICO20 Summit in Santa Monica, CA.
Integration of smart contract technology is established.
Company headquarters incorporated in Gibraltar, GB.
Strategic efforts toward development begins.
Interviews with potential medical participants take place.
Whitelist is scheduled to go live.
Token Sale starts.
Token Sale ends and min max caps are assessed.
Distribution of Tokens to participants through ERC20 will commence.
SCI will begin final testing and reporting based on blockchain technology being used.
Creation of a non-identical patient identification factor on Passive Blockchain Node will be initialized.
Demo testing for SCI Application v 1.0 will begin.
Release of the SCI Application v1.1
Enrollment begins for doctors, patients, and stem cell laboratories in the United States
Release of Market Surveillance strategy for further growth
Release SCI Application v2.0
Enrollment begins for professionals, patients, and stem cell laboratories in Middle East and across North Africa.
Announcement of first SCI Lab location and franchise expansion plan.
Announcement of clinical development and research strategy in the stem cell field.
Public announcement regarding SCI achievements to date.
First ever online synthetic stem cell purchase through the SCI Application. Release SCI Application v3.0, fully functional platform for professionals and patients.
Stem Cell Lab Evaluation report per first year of operation and development.
Release SCI earnings and financials report.
Release results of SCI's stem cell research and development to date.
Expansion of SCI stem cell labs and clinics in China, Japan, South Korea, and India.
Begin charging membership fees (payable in Stem Cell Innovations tokens) for professional-facing portion of SCI application.
Begin second phase of SCI stem cell research and development.
Release SCI Application v3.5, including professional-facing component to help practitioners become more involved in the stem cell research space and contribute to the network.
Expansion and acquisition of SCI stem cell labs and clinics in Europe.
Release SCI earnings and financials report for second year operation and development.
Release public update on SCI stem cell research and development.
Stem Cell Lab Evaluation report for second year.
Release SCI Application v4.0 including:
A new platform for medical students, universities, and hospitals to engage with the SCI Application.
Fully Functional EMR Worldwide Enforcing HIPPA and expanding of synthetic stem cell delivery to Latin America.
|PortalSoho.com does not encourage investing in any ICOs published on the platform. Make sure to do your own thorough research before putting money into Initial Coin Offerings. All content on PortalSoho.com is meant to be used for information purposes only, and should not be taken as financial or investment advice.|
|Author : asrinur||Bitcointalk BountyHive|
ETH (ERC-20) Address: 0x86Ad36da59310683CfE8C2c66e798D2e636413fF
Bitcoin Address: 16DcB1iCq9rQ4PKQZUU8XhNcQ5qRCPmGsZ